Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 5;15(7):2150.
doi: 10.3390/cancers15072150.

Development and Evaluation of MR-Based Radiogenomic Models to Differentiate Atypical Lipomatous Tumors from Lipomas

Affiliations

Development and Evaluation of MR-Based Radiogenomic Models to Differentiate Atypical Lipomatous Tumors from Lipomas

Sarah C Foreman et al. Cancers (Basel). .

Abstract

Background: The aim of this study was to develop and validate radiogenomic models to predict the MDM2 gene amplification status and differentiate between ALTs and lipomas on preoperative MR images.

Methods: MR images were obtained in 257 patients diagnosed with ALTs (n = 65) or lipomas (n = 192) using histology and the MDM2 gene analysis as a reference standard. The protocols included T2-, T1-, and fat-suppressed contrast-enhanced T1-weighted sequences. Additionally, 50 patients were obtained from a different hospital for external testing. Radiomic features were selected using mRMR. Using repeated nested cross-validation, the machine-learning models were trained on radiomic features and demographic information. For comparison, the external test set was evaluated by three radiology residents and one attending radiologist.

Results: A LASSO classifier trained on radiomic features from all sequences performed best, with an AUC of 0.88, 70% sensitivity, 81% specificity, and 76% accuracy. In comparison, the radiology residents achieved 60-70% accuracy, 55-80% sensitivity, and 63-77% specificity, while the attending radiologist achieved 90% accuracy, 96% sensitivity, and 87% specificity.

Conclusion: A radiogenomic model combining features from multiple MR sequences showed the best performance in predicting the MDM2 gene amplification status. The model showed a higher accuracy compared to the radiology residents, though lower compared to the attending radiologist.

Keywords: MRI; machine learning; radiology; radiomics; soft-tissue sarcomas.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Subject selection flowchart. ALT = atypical lipomatous tumor; MDM2 = murine double minute.
Figure 2
Figure 2
Radiomic workflow. Abbreviations: SVM, support vector machine; LASSO, least absolute shrinkage and selection operator; ANN, artificial neural network.
Figure 3
Figure 3
Lipomatous tumor in the medial right thigh, encasing the gracilis muscle (G). (A) The axial T2-weighted and (B) axial T1-weighted MR images show a large heterogeneous tumor with thick septa. (C) Septal contrast enhancement on the coronal T1-weighted images with fat saturation. (D) The machine-learning algorithm classified the tumor as an ALT with a probability of 99.8%. This diagnosis was confirmed by pathology and immunohistochemistry after surgical resection.
Figure 4
Figure 4
Axial T2-weighted (A) and T1-weighted (B) MR images showing a well-defined intramuscular lipomatous tumor (lipoma) in the right posterior thigh without significant contrast enhancement on the axial T1-weighted image with fat saturation (C). (D) The machine-learning model classified this tumor as a lipoma (probability of 97.8%). This was in accordance with the diagnosis made by the radiology residents and the attending radiologist.
Figure 5
Figure 5
Sagittal T2-weighted (A) and axial T1-weighted (B) MR images of a lipomatous tumor located subcutaneously, anteromedial to the right proximal tibia. (C) A sagittal T1-weighted image with fat saturation shows a moderate septal contrast enhancement. All radiology residents classified this tumor as a lipoma, while the attending radiologist classified this tumor as an ALT. (D) The machine-learning algorithm also classified this tumor as an ALT with a probability of 71.6%. The diagnosis of an ALT was confirmed by pathology after surgical resection.

References

    1. Johnson C.N., Ha A.S., Chen E., Davidson D. Lipomatous Soft-tissue Tumors. J. Am. Acad. Orthop. Surg. 2018;26:779–788. doi: 10.5435/JAAOS-D-17-00045. - DOI - PubMed
    1. Dalal K.M., Antonescu C.R., Singer S. Diagnosis and management of lipomatous tumors. J. Surg. Oncol. 2008;97:298–313. doi: 10.1002/jso.20975. - DOI - PubMed
    1. Myhre-Jensen O., Kaae S., Madsen E.H., Sneppen O. Histopathological grading in soft-tissue tumours. Relation to survival in 261 surgically treated patients. Acta Pathol. Microbiol. Immunol. Scand. A. 1983;91:145–150. - PubMed
    1. Rydholm A., Berg N.O. Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma. Acta Orthop. Scand. 1983;54:929–934. doi: 10.3109/17453678308992936. - DOI - PubMed
    1. Fletcher C.D. The evolving classification of soft tissue tumours: An update based on the new WHO classification. Histopathology. 2006;48:3–12. doi: 10.1111/j.1365-2559.2005.02284.x. - DOI - PubMed